Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Alex Toker

Novel regulation of PI3K/Akt to direct targeted breast cancer therapies

Breast

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Hodgkin lymphoma Non-Hodgkin lymphoma

Stanley R. Riddell

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Leukaemia Non-Hodgkin lymphoma

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Breast Non-Hodgkin lymphoma

Emily Smith Tonorezos

Exercise and QUality diet After Leukemia

Leukaemia

Pediatric oncology or childhood cancer

Wing Leung

KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN

Leukaemia

Pediatric oncology or childhood cancer

Oliver W. Press

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma